A comparative study of the effects of quercetin and its glucuronide and sulfate metabolites on human neutrophil function in vitro

Biochemical Pharmacology

Volumn 76, Issue 5, 2008, Pages 645-653

  Suri, Sunita ^a   Taylor, Moira A ^a   Verity, Anne ^a   Tribolo, Sandra ^b   Needs, Paul W ^b   Kroon, Paul A ^b   Hughes, David A ^b   Wilson, Vincent G ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NORWICH RESEARCH PARK   (United Kingdom)

Author keywords

Adhesion molecules; Flavonoids; Human neutrophils; Inflammation; Intracellular calcium; Quercetin metabolites

Indexed keywords

BETA2 INTEGRIN; CALCIUM; CD16 ANTIGEN; CELL ADHESION MOLECULE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GLUCURONIDE; L SELECTIN; LIPOPOLYSACCHARIDE; QUERCETIN; QUERCETIN 3 GLUCURONIDE; QUERCETIN 3' SULFATE; SULFATE; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL FUNCTION; CELL SHAPE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; METABOLITE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HUMANS; ION TRANSPORT; LIPOPOLYSACCHARIDES; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; QUERCETIN; RECEPTORS, IGG;

EID: 49149102015     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.06.010     Document Type: Article

References (42)

1. 2+ in human neutrophil responses to receptor agonists. Biochem J 277 (1991) 705-711
2. Tintinger G., Steel H.C., and Anderson R. Taming the neutrophil: calcium clearance and influx mechanisms as novel targets for pharmacological control. Clin Exp Immunol 141 (2005) 191-200
3. 2+. Biochem J 269 (1990) 513-519
4. Raetz C.R. Biochemistry of endotoxins. Annu Rev Biochem 59 (1990) 129-170
5. Howard T.H., Wang D., and Berkow R.L. Lipopolysaccharide modulates chemotactic peptide-induced actin polymerization in neutrophils. J Leukoc Biol 47 (1990) 13-24
6. Ravetch J.V., and Kinet J.P. Fc receptors. Annu Rev Immunol 9 (1991) 457-492
7. Nagaoka I., Niyonsaba F., Tsutsumi-Ishii Y., Tamura H., and Hirata M. Evaluation of the effect of human beta-defensins on neutrophil apoptosis. Int Immunol 20 (2008) 543-553
8. Manach C., Williamson G., Morand C., Scalbert A., and Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81 (2005) 230S-242S
9. Knekt P., Jarvinen R., Reunanen A., and Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ 312 (1996) 478-481
10. Knekt P., Kumpulainen J., Jarvinen R., Rissanen H., Heliovaara M., Reunanen A., et al. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76 (2002) 560-568
11. Hertog M.G., Feskens E.J., Hollman P.C., Katan M.B., and Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342 (1993) 1007-1011
12. Hertog M.G., Sweetnam P.M., Fehily A.M., Elwood P.C., and Kromhout D. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr 65 (1997) 1489-1494
13. Hertog M.G., Feskens E.J., and Kromhout D. Antioxidant flavonols and coronary heart disease risk. Lancet 349 (1997) 699
14. Wittig J., Herderich M., Graefe E.U., and Veit M. Identification of quercetin glucuronides in human plasma by high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B: Biomed Sci Appl 753 (2001) 237-243
15. Day A.J., Mellon F., Barron D., Sarrazin G., Morgan M.R., and Williamson G. Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic Res 35 (2001) 941-952
16. Mullen W., Boitier A., Stewart A.J., and Crozier A. Flavonoid metabolites in human plasma and urine after the consumption of red onions: analysis by liquid chromatography with photodiode array and full scan tandem mass spectrometric detection. J Chromatogr A 1058 (2004) 163-168
17. Mullen W., Edwards C.A., and Crozier A. Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions. Br J Nutr 96 (2006) 107-116
18. Wang L., and Morris M.E. Liquid chromatography-tandem mass spectroscopy assay for quercetin and conjugated quercetin metabolites in human plasma and urine. J Chromatogr B: Anal Technol Biomed Life Sci 821 (2005) 194-201
19. Saeed S.A., Connor J.D., Imran, Quadri J., Tasneem S., Ahmed S., et al. Inhibitors of phosphatidylinositide 3-kinase: effects on reactive oxygen species and platelet aggregation. Pharmacol Rep 59 (2007) 238-243
20. Liu J., Li X., Yue Y., Li J., He T., and He Y. The inhibitory effect of quercetin on IL-6 production by LPS-stimulated neutrophils. Cell Mol Immunol 2 (2005) 455-460
21. Liu J.J., Song C.W., Yue Y., Duan C.G., Yang J., He T., et al. Quercetin inhibits LPS-induced delay in spontaneous apoptosis and activation of neutrophils. Inflamm Res 54 (2005) 500-507
22. Takemura O.S., Banno Y., and Nozawa Y. Inhibition of N-formylmethionyl-leucyl-phenylalanine-stimulated tyrosine phosphorylation and phospholipase D activation by quercetin in rabbit neutrophils. Biochem Pharmacol 53 (1997) 1503-1510
23. Bouriche H., Miles E.A., Selloum L., and Calder P.C. Effect of Cleome arabica leaf extract, rutin and quercetin on soybean lipoxygenase activity and on generation of inflammatory eicosanoids by human neutrophils. Prostaglandins Leukot Essent Fatty Acids 72 (2005) 195-201
24. de Pascual-Teresa S., Johnston K.L., DuPont M.S., O'Leary K.A., Needs P.W., Morgan L.M., et al. Quercetin metabolites downregulate cyclooxygenase-2 transcription in human lymphocytes ex vivo but not in vivo. J Nutr 134 (2004) 552-557
25. Needs P.W., and Kroon P.A. Convenient syntheses of metabolically important quercetin glucuronides and sulfates. Tetrahedron 62 (2006) 6862-6868
26. Nieman D.C., Henson D.A., Davis J.M., Angela M.E., Jenkins D.P., Gross S.J., et al. Quercetin's influence on exercise-induced changes in plasma cytokines and muscle and leukocyte cytokine mRNA. J Appl Physiol 103 (2007) 1728-1735
27. Loke W.M., Proudfoot J.M., Stewart S., McKinley A.J., Needs P.W., Kroon P.A., et al. Metabolic transformation has a profound effect on anti-inflammatory activity of flavonoids such as quercetin: lack of association between antioxidant and lipoxygenase inhibitory activity. Biochem Pharmacol 75 (2008) 1045-1053
28. Springer T.A. Adhesion receptors of the immune system. Nature 346 (1990) 425-434
29. Ruotsalainen M., and Savolainen K.M. The role of G-proteins in the activation of human leukocytes by particulate stimuli to produce reactive oxygen metabolites. Toxicology 99 (1995) 67-76
30. Borregaard N., and Cowland J.B. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89 (1997) 3503-3521
31. Lu H.W., Sugahara K., Sagara Y., Masuoka N., Asaka Y., Manabe M., et al. Effect of three flavonoids, 5,7,3′,4′-tetrahydroxy-3-methoxy flavone, luteolin, and quercetin, on the stimulus-induced superoxide generation and tyrosyl phosphorylation of proteins in human neutrophil. Arch Biochem Biophys 393 (2001) 73-77
32. Selloum L., Reichl S., Muller M., Sebihi L., and Arnhold J. Effects of flavonols on the generation of superoxide anion radicals by xanthine oxidase and stimulated neutrophils. Arch Biochem Biophys 395 (2001) 49-56
33. Kroon P.A., Clifford M.N., Crozier A., Day A.J., Donovan J.L., Manach C., et al. How should we assess the effects of exposure to dietary polyphenols in vitro?. Am J Clin Nutr 80 (2004) 15-21
34. Donnini S., Finetti F., Lusini L., Morbidelli L., Cheynier V., Barron D., et al. Divergent effects of quercetin conjugates on angiogenesis. Br J Nutr 95 (2006) 1016-1023
35. Tribolo S., Lodi F., Connor C., Suri S., Wilson V.G., Taylor M.A., et al. Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells. Atherosclerosis 197 (2008) 50-56
36. Koga T., and Meydani M. Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells. Am J Clin Nutr 73 (2001) 941-948
37. Kawai Y., Nishikawa T., Shiba Y., Saito S., Murota K., Shibata N., et al. Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids. J Biol Chem 283 (2008) 9424-9434
38. Shimoi K., Saka N., Nozawa R., Sato M., Amano I., Nakayama T., et al. Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation. Drug Metab Dispos 29 (2001) 1521-1524
39. Janssen K., Mensink R.P., Cox F.J., Harryvan J.L., Hovenier R., Hollman P.C., et al. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr 67 (1998) 255-262
40. Hubbard G.P., Wolffram S., Lovegrove J.A., and Gibbins J.M. Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. J Thromb Haemost 2 (2004) 2138-2145
41. Hubbard G.P., Stevens J.M., Cicmil M., Sage T., Jordan P.A., Williams C.M., et al. Quercetin inhibits collagen-stimulated platelet activation through inhibition of multiple components of the glycoprotein VI signaling pathway. J Thromb Haemost 1 (2003) 1079-1088
42. Boman H.G. Antibacterial peptides: basic facts and emerging concepts. J Intern Med 254 (2003) 197-215